Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
37.00
Dollar change
-0.30
Percentage change
-0.80
%
IndexRUT P/E- EPS (ttm)-0.52 Insider Own60.04% Shs Outstand8.54M Perf Week-1.91%
Market Cap318.94M Forward P/E66.07 EPS next Y0.56 Insider Trans0.00% Shs Float3.45M Perf Month-1.62%
Income-4.30M PEG- EPS next Q-0.07 Inst Own7.96% Short Float4.18% Perf Quarter-10.39%
Sales64.99M P/S4.91 EPS this Y57.69% Inst Trans27.73% Short Ratio10.54 Perf Half Y11.75%
Book/sh5.25 P/B7.04 EPS next Y354.55% ROA-6.38% Short Interest0.14M Perf Year-2.91%
Cash/sh0.60 P/C61.93 EPS next 5Y- ROE-9.93% 52W Range26.06 - 50.18 Perf YTD-9.98%
Dividend Est.- P/FCF- EPS past 5Y- ROI-7.73% 52W High-26.27% Beta1.57
Dividend TTM- Quick Ratio1.04 Sales past 5Y50.60% Gross Margin82.26% 52W Low41.98% ATR (14)1.36
Dividend Ex-Date- Current Ratio1.38 EPS Y/Y TTM65.34% Oper. Margin-11.79% RSI (14)48.99 Volatility3.25% 3.08%
Employees107 Debt/Eq0.26 Sales Y/Y TTM41.77% Profit Margin-6.62% Recom1.00 Target Price49.00
Option/ShortNo / Yes LT Debt/Eq0.24 EPS Q/Q94.38% Payout- Rel Volume0.58 Prev Close37.30
Sales Surprise7.27% EPS Surprise76.92% Sales Q/Q15.50% EarningsMar 25 AMC Avg Volume13.67K Price37.00
SMA20-0.48% SMA500.04% SMA2001.72% Trades Volume7,868 Change-0.80%
Date Action Analyst Rating Change Price Target Change
May-20-22Resumed Cantor Fitzgerald Overweight $45 → $40
Jun-30-21Initiated Cantor Fitzgerald Overweight $45
Mar-25-24 08:53PM
05:52PM
04:05PM
Mar-13-24 09:15AM
Feb-22-24 09:15AM
09:15AM Loading…
Jan-03-24 09:15AM
Nov-30-23 09:15AM
Nov-15-23 01:44PM
Nov-13-23 05:29PM
04:05PM
Oct-30-23 09:15AM
Oct-10-23 09:15AM
Sep-12-23 09:15AM
Aug-14-23 04:05PM
Aug-02-23 09:15AM
04:05PM Loading…
Aug-01-23 04:05PM
May-15-23 04:15PM
May-03-23 09:15AM
Apr-04-23 09:15AM
Mar-20-23 04:15PM
Mar-06-23 09:15AM
Feb-22-23 09:15AM
Nov-21-22 09:15AM
Nov-14-22 04:15PM
Nov-03-22 09:15AM
06:30AM
Nov-01-22 09:15AM
Sep-06-22 09:15AM
Aug-17-22 08:44AM
Aug-15-22 04:15PM
06:29AM Loading…
Aug-11-22 06:29AM
Aug-03-22 09:15AM
Jul-05-22 09:15AM
Jun-12-22 10:12AM
May-16-22 04:30PM
May-11-22 07:42AM
May-02-22 09:15AM
Apr-18-22 09:31AM
Apr-04-22 06:45PM
06:30AM
Mar-30-22 04:15PM
Mar-14-22 09:15AM
Mar-04-22 08:06AM
Feb-22-22 09:15AM
Jan-03-22 01:02PM
Dec-28-21 09:15AM
Dec-22-21 04:05PM
Dec-15-21 09:15AM
Nov-12-21 04:15PM
Nov-09-21 09:15AM
Nov-03-21 01:25PM
Oct-28-21 09:15AM
Sep-22-21 09:15AM
Sep-03-21 01:01PM
Aug-26-21 09:15AM
Aug-16-21 04:15PM
Aug-02-21 09:15AM
Jul-19-21 09:15AM
Jul-05-21 09:08AM
Jun-04-21 09:15AM
May-17-21 09:15AM
Mar-31-21 09:15AM
Feb-17-21 12:00PM
Feb-12-21 09:20AM
Feb-11-21 04:01PM
Feb-02-21 05:32AM
Jan-25-21 04:10PM
Dec-23-20 09:15AM
Nov-13-20 04:45PM
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McNeil Michael D.Chief Financial OfficerApr 12 '23Option Exercise6.001,0006,00023,025Apr 14 04:30 PM